CN1190390A - 由环状脒衍生的氧化氮合成酶抑制剂 - Google Patents
由环状脒衍生的氧化氮合成酶抑制剂 Download PDFInfo
- Publication number
- CN1190390A CN1190390A CN96195400A CN96195400A CN1190390A CN 1190390 A CN1190390 A CN 1190390A CN 96195400 A CN96195400 A CN 96195400A CN 96195400 A CN96195400 A CN 96195400A CN 1190390 A CN1190390 A CN 1190390A
- Authority
- CN
- China
- Prior art keywords
- hydrogen
- low
- alkyl group
- group
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43832195A | 1995-05-10 | 1995-05-10 | |
US08/438,321 | 1995-05-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1190390A true CN1190390A (zh) | 1998-08-12 |
Family
ID=23740193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96195400A Pending CN1190390A (zh) | 1995-05-10 | 1996-05-09 | 由环状脒衍生的氧化氮合成酶抑制剂 |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0824523A1 (fr) |
JP (1) | JPH11511741A (fr) |
KR (1) | KR19990014671A (fr) |
CN (1) | CN1190390A (fr) |
AU (1) | AU712995B2 (fr) |
BR (1) | BR9608133A (fr) |
CA (1) | CA2218360A1 (fr) |
MX (1) | MX9708631A (fr) |
NZ (1) | NZ307950A (fr) |
TW (1) | TW415941B (fr) |
WO (1) | WO1996035677A1 (fr) |
ZA (1) | ZA963742B (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6043358A (en) | 1995-11-01 | 2000-03-28 | Merck & Co., Inc. | Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
GB9524526D0 (en) * | 1995-11-30 | 1996-01-31 | Zeneca Ltd | Chemical process |
AU5813098A (en) * | 1997-01-09 | 1998-08-03 | G.D. Searle & Co. | Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
US6110930A (en) * | 1997-04-10 | 2000-08-29 | Ono Pharmaceutical Co., Ltd. | Condensed piperidine compound |
US6552052B2 (en) | 1998-06-10 | 2003-04-22 | Monsanto/G.D. Searle | Pyrrolo[2,1-c][1,2,4] thiadiazoles and Pyrollo[2,1-c][1,12,4]oxadiazoles useful as nitric oxide synthase inhibitors |
EP1086108A1 (fr) | 1998-06-10 | 2001-03-28 | G.D. Searle & Co. | Inhibiteurs heterobicycliques et tricycliques de no synthetase |
SE9901530D0 (sv) * | 1999-04-28 | 1999-04-28 | Astra Pharma Prod | Novel compounds |
ES2256223T3 (es) | 2000-03-24 | 2006-07-16 | Pharmacia Corporation | Amidinocompuestos utiles como inhibidores de oxido nitrico sintasa. |
US6787668B2 (en) | 2000-04-13 | 2004-09-07 | Pharmacia Corporation | 2-amino-4,5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
AR034120A1 (es) | 2000-04-13 | 2004-02-04 | Pharmacia Corp | Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico |
AR032318A1 (es) | 2000-04-13 | 2003-11-05 | Pharmacia Corp | Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa |
US6545170B2 (en) | 2000-04-13 | 2003-04-08 | Pharmacia Corporation | 2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
AR030416A1 (es) | 2000-04-13 | 2003-08-20 | Pharmacia Corp | COMPUESTO DERIVADO HALOGENADO DEL ACIDO 2-AMINO-3,4 HEPTENOICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE Y SU USO EN LA FABRICACION DE UN MEDICAMENTO uTIL COMO INHIBIDOR DE LA OXIDO NITRICO SINTETASA |
US6956131B2 (en) | 2000-04-13 | 2005-10-18 | Pharmacia Corporation | 2-amino-3, 4 heptenoic compounds useful as nitric oxide synthase inhibitors |
US7012098B2 (en) | 2001-03-23 | 2006-03-14 | Pharmacia Corporation | Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
JPWO2003022309A1 (ja) * | 2001-09-10 | 2004-12-24 | 小野薬品工業株式会社 | アレルギー疾患治療剤 |
JP5662431B2 (ja) * | 2009-06-12 | 2015-01-28 | エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム | 癌の光線力学療法のための標的化されたナノフォトメディスン |
WO2011038204A1 (fr) | 2009-09-25 | 2011-03-31 | N30 Pharmaceuticals, Llc | Nouveaux composés dihydropyrimidine-2(1h)-ones en tant qu'inhibiteurs de la s-nitrosoglutathion réductase |
ES2550939T3 (es) | 2010-07-16 | 2015-11-13 | Nivalis Therapeutics, Inc. | Nuevos compuestos de dihidropiridin-2-(1H)-ona como inhibidores de la S-nitrosoglutatión reductasa y antagonistas del receptor de la neurocinina-3 |
WO2012039718A1 (fr) | 2010-09-24 | 2012-03-29 | N30 Pharmaceuticals, Llc | Composés innovants de dihydropyrimidine-2(1h)-un en tant qu'antagonistes des récepteurs de neurokinine-3 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2049582A (en) * | 1931-11-04 | 1936-08-04 | Rohm & Haas | Amidines |
US3121093A (en) * | 1962-08-31 | 1964-02-11 | Rohm & Haas | Substituted iminopyrrolidines |
EP0724570B1 (fr) * | 1993-10-21 | 1999-03-03 | G.D. Searle & Co. | Derives amidino utiles en tant qu'inhibiteurs de la synthase de l'oxyde nitrique |
US5629322A (en) * | 1994-11-15 | 1997-05-13 | Merck & Co., Inc. | Cyclic amidine analogs as inhibitors of nitric oxide synthase |
-
1996
- 1996-05-09 NZ NZ307950A patent/NZ307950A/xx unknown
- 1996-05-09 JP JP8534320A patent/JPH11511741A/ja not_active Abandoned
- 1996-05-09 WO PCT/US1996/006831 patent/WO1996035677A1/fr not_active Application Discontinuation
- 1996-05-09 MX MX9708631A patent/MX9708631A/es unknown
- 1996-05-09 BR BR9608133A patent/BR9608133A/pt not_active Application Discontinuation
- 1996-05-09 EP EP96915767A patent/EP0824523A1/fr not_active Withdrawn
- 1996-05-09 AU AU57454/96A patent/AU712995B2/en not_active Ceased
- 1996-05-09 KR KR1019970708012A patent/KR19990014671A/ko not_active Application Discontinuation
- 1996-05-09 CN CN96195400A patent/CN1190390A/zh active Pending
- 1996-05-09 CA CA002218360A patent/CA2218360A1/fr not_active Abandoned
- 1996-05-10 ZA ZA963742A patent/ZA963742B/xx unknown
- 1996-08-06 TW TW085109538A patent/TW415941B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ307950A (en) | 1999-06-29 |
BR9608133A (pt) | 1999-02-09 |
CA2218360A1 (fr) | 1996-11-14 |
AU712995B2 (en) | 1999-11-18 |
EP0824523A1 (fr) | 1998-02-25 |
WO1996035677A1 (fr) | 1996-11-14 |
TW415941B (en) | 2000-12-21 |
ZA963742B (en) | 1997-07-09 |
MX9708631A (es) | 1998-02-28 |
AU5745496A (en) | 1996-11-29 |
KR19990014671A (ko) | 1999-02-25 |
JPH11511741A (ja) | 1999-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1190390A (zh) | 由环状脒衍生的氧化氮合成酶抑制剂 | |
CN1035616C (zh) | 异羟肟酸衍生物 | |
CN1206228C (zh) | 作为nos抑制剂的n-杂环衍生物 | |
CN1145616C (zh) | 新的氨基三唑化合物,其制备方法及包含它们的药物组合物 | |
CN1105706C (zh) | 用作氧化氮合成酶抑制剂的环状脒基制剂 | |
CN1100534C (zh) | 2-(1h-4(5)-咪唑基环丙基衍生物及含该衍生物的药物组合物和其制备方法 | |
CN1077886C (zh) | 用作一氧化一氮合酶抑制剂的脒基衍生物 | |
CN1043348C (zh) | 不对称取代的黄嘌呤、其制备方法及其作为药物组合物的应用 | |
CN1228087A (zh) | 取代的嘧啶衍生物和它们的药物用途 | |
CN87102972A (zh) | 治疗老年性痴呆有效的二唑 | |
CN1060285A (zh) | 含氮非芳香杂环的稠环类似物 | |
CN1845921A (zh) | 金刚烷和氮杂双环-辛烷及壬烷衍生物、其制备方法及其作为dpp-iv抑制剂的用途 | |
CN1088582A (zh) | 碱式季酰胺,其制备方法及其药物组合物 | |
CN1468239A (zh) | 取代的吡唑 | |
CN1106806A (zh) | 粘结受体拮抗剂iii | |
CN1030409A (zh) | 吲哚衍生物及其制备方法 | |
CN1440406A (zh) | 黑皮质素受体配体 | |
CN1344160A (zh) | 用作生长激素促分泌剂的杂环芳族化合物 | |
CN1067889A (zh) | 取代的n-(1-烷基-3-羟基-4-哌啶基)苯甲酰胺的制备方法 | |
CN1606545A (zh) | 作为nk1拮抗剂的吡咯烷和哌啶衍生物 | |
CN1059141A (zh) | 苯并二氮杂衍生物 | |
CN1085216A (zh) | 具有抑制腺苷再吸收作用的二苯基噁唑、噻唑和咪唑衍生物 | |
CN1018614B (zh) | 制备含n-杂环基-4-哌啶胺类的抗组胺组合物的方法 | |
CN1030452C (zh) | 2-氨基嘧啶酮衍生物的制备方法 | |
CN1124734A (zh) | 噻嗪-或硫氮杂䓬衍生物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |